JLJishan Li

Jishan Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jishan Li has a total of 144 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Two-Color Digital Immunoassay for Simultaneous Detection of Low-Abundance Neurodegenerative Disease Protein Biomarkers

    by Ruiying Peng, Daian Chen, Ting Deng, Jishan Li, Jian-Hui Jiang

    We developed a novel two-color digital immunoassay platform for the simultaneous detection of neurodegenerative disease protein biomarkers (neurofilament light chain (NfL) and interleukin-6 (IL-6)) in a homogeneous, wash-free format. This multiplex approach employs two antibody pairs: capture antibodies conjugated with porphyrin-metal organic framework (pMOF) as singlet oxygen (1O2) nanogenerators, and detection antibodies functionalized with spectrally distinct upconversion nanoparticles (UCNPs) serving as nanoreporters─specifically BHQ2-modified Er3+-doped UCNPs for NfL detection and dabsyl-modified Tm3+-doped UCNPs for IL-6 detection, both with luminescence caged by 1O2-cleavable quenchers. Antigen binding formed immunocomplexes between nanoprobe pairs, triggering specific luminescence activation in distinct channels: green emission at 540 nm for NfL and blue emission at 475 nm for IL-6. The spatially restricted diffusion radius of pMOF-generated 1O2 ensured the selective cleavage of proximal quenchers, enabling digital quantification via single-molecule fluorescence imaging. The platform demonstrated exceptional sensitivity with cross-talk-free performance, achieving detection limits of 25 aM for NfL and 11 aM for IL-6. Serum analysis confirmed the biosensor's potential for comprehensive neurological biomarker detection, establishing its utility for large-scale neurodegenerative disease screening.

  • Proximity Singlet-Oxygen-Activation and Luminescence-Controllable Chemiluminescent Assay for Fast Ultrasensitive Detection of Pathogenic Bacteria

    by Daian Chen, Ling Xie, Ruiying Peng, Ting Deng, Jishan Li

    In this study, a novel proximity singlet oxygen (1O2)-activation and luminescence-controllable chemiluminescent assay (PALCA) was developed for ultrasensitively detecting pathogenic bacteria. The PALCA system comprised an antimicrobial peptide-coated porphyrin-metal organic framework (pMOF) as a 1O2-generator and a polymyxin B-functionalized polystyrene nanosphere loaded with borate-caged adamantan-1,2-dioxy-cyclobutane chemiluminescent precursor molecules (CPMs) as a chemiluminescence reporter. Both the 1O2-generator and chemiluminescence reporter were bound to the surfaces of pathogenic bacteria, thereby reducing the distance between nanoprobes. The reduced distance enabled a high concentration of pMOF-generated 1O2 under light irradiation to diffuse to the chemiluminescence reporter, oxidizing the embedded CPMs into adamantan-1,2-dioxy-cyclobutane. After the addition of the decaging-reagent of H2O2, the intensities of chemiluminescence signals were more pronounced, leading to the detection of target bacteria. The entire detection process was achieved in one test tube within 30 min, eliminating the need for separation and washing processes. The pathogenic bacteria were ultrasensitively detected at a limit of detection of 1.8 cfu/mL. This proposed PALCA is simple, fast, and ultrasensitive, exhibiting great potential in practical applications.

  • CRISPR-Cas-Mediated Ultrasensitive Detection of Viral Nucleic Acids via Singlet Oxygen-Activated Chemiluminescence

    by Fei Chen, Daian Chen, Ting Deng, Jishan Li, Jian-Hui Jiang

    Herein, we report a novel clustered regularly interspaced short palindromic repeats (CRISPR)/Cas-mediated chemiluminescence assay (CRISPR-Cas-CLA) for the ultrasensitive detection of viral nucleic acids of HPV18 and HPV16. The CRISPR-Cas-CLA comprises a CRISPR/Cas12a system that specifically recognizes the target nucleic acid, a signal-conducting nanoconjugate (MB-ssDNA-PSNP) formed by coupling singlet-oxygen (1O2)-generating photosensitive nanoparticles (PSNPs) to magnetic beads (MBs) via a single-stranded DNA (ssDNA) linker, and 1O2-activated chemiluminescence nanoparticles (CLNPs). In the presence of the target nucleic acid, the ssDNA linker of the nanoconjugate is cleaved by the target-activated CRISPR/Cas12a system, and the PSNPs are dissociated from the MBs. The PSNP-containing supernatant obtained by magnetic separation is added to the CLNP-coated detection plate. Upon light irradiation of the CLNP-PSNP mixture in the well, strong chemiluminescence is generated with the subsequent addition of hydrogen peroxide, enabling the detection of the target nucleic acids. The proposed CRISPR-Cas-CLA system offers ultrahigh sensitivity (∼1.04 aM), simple operation, and low cost, providing a new direction for the development of PCR-free detection strategies for ultralow abundance nucleic acids.


  • Single-Cell Detection of Circulating Tumor Cells by a Proximity-Enabled Singlet-Oxygen Chemiluminescence Assay

    by Fei Chen, Daian Chen, Ting Deng, Jishan Li, Jian-Hui Jiang

    Circulating tumor cell (CTC) assays with single-cell sensitivity and efficient implementation are critically needed in clinic applications, especially for cancer screening. We report a novel proximity-enabled singlet-oxygen chemiluminescence assay (PESCA) that enables low-cost and efficient CTC detection with single-cell sensitivity. The PESCA system is based on proximity labeling of cell-surface oncoprotein markers on CTCs using two types of polymer nanoparticles, one for generating singlet oxygen (1O2) and the other for activating chemiluminescence upon 1O2 sensitization and H2O2 decaging. A hybridization chain reaction (HCR) is exploited for triggering the proximity labeling, allowing efficient sensitization of the chemiluminescence signal specific to CTCs with signal amplification to enable robust single-cell resolution. The PESCA method can accomplish digital counting of CTCs in a whole blood sample with a detection efficiency of 80% for 10 CTCs in 7.5 mL of whole blood, highlighting its potential for cancer screening in clinic applications.


  • Ultrasensitive Digital Immunoassay in Homogenous Format by Singlet‐Oxygen Activated Up‐conversion Luminescence

    by Ruiying Peng, Yanli Ji, Daian Chen, Zhan Wu, Jishan Li, Zhaohui Li, Jian‐Hui Jiang

    New diagnostic tools for accurately detecting extremely low levels of protein biomarkers in the bloodstream are essential for a wide range of clinical applications. We develop a singlet‐oxygen activated up‐conversion luminescence assay (SOLA) that enables ultrasensitive digital immunometric detection of protein biomarkers in homogenous format with no wash steps. This approach designs a pair of labeled antibodies, one labeled with a singlet‐oxygen ( 1 O 2 ) nanogenerator of porphyrin‐metal organic framework (pMOF) and the other tagged using an upconversion nanoparticle (UCNP) nanoreporter with luminescence caged by 1 O 2 ‐cleavable quenchers. Formation of sandwiched complex between target protein and antibody pairs mediates close proximity between 1 O 2 ‐generator and UCNP reporter, enabling efficient diffusion of 1 O 2 around the reporter to activate its luminescence through cleaving off the quenchers. This approach is demonstrated to be capable of activating detectable fluorescence from a single UCNP reporter with a single‐molecule protein target. A digital homogeneous immunoassay strategy is also developed for ultrasensitive protein detection, allowing a single‐step, no‐wash format for digital protein detection with high signal‐to‐background ratio, wide dynamic range and atto‐molar detection limit. The SOLA assay may provide an invaluable paradigm for developing highly accessible and ultrasensitive tools for diagnostics and biomarker discovery.

  • Ultrasensitive Digital Immunoassay in Homogenous Format by Singlet‐Oxygen Activated Up‐conversion Luminescence

    by Ruiying Peng, Yanli Ji, Daian Chen, Zhan Wu, Jishan Li, Zhaohui Li, Jian‐Hui Jiang

    New diagnostic tools for accurately detecting extremely low levels of protein biomarkers in the bloodstream are essential for a wide range of clinical applications. We develop a singlet‐oxygen activated up‐conversion luminescence assay (SOLA) that enables ultrasensitive digital immunometric detection of protein biomarkers in homogenous format with no wash steps. This approach designs a pair of labeled antibodies, one labeled with a singlet‐oxygen ( 1 O 2 ) nanogenerator of porphyrin‐metal organic framework (pMOF) and the other tagged using an upconversion nanoparticle (UCNP) nanoreporter with luminescence caged by 1 O 2 ‐cleavable quenchers. Formation of sandwiched complex between target protein and antibody pairs mediates close proximity between 1 O 2 ‐generator and UCNP reporter, enabling efficient diffusion of 1 O 2 around the reporter to activate its luminescence through cleaving off the quenchers. This approach is demonstrated to be capable of activating detectable fluorescence from a single UCNP reporter with a single‐molecule protein target. A digital homogeneous immunoassay strategy is also developed for ultrasensitive protein detection, allowing a single‐step, no‐wash format for digital protein detection with high signal‐to‐background ratio, wide dynamic range and atto‐molar detection limit. The SOLA assay may provide an invaluable paradigm for developing highly accessible and ultrasensitive tools for diagnostics and biomarker discovery.